Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions

Alexandru Hasan; Simona Cavalu; Ahmed Kira; Rabab Hamad; Mustafa Abdel-Reheim; Elsayed Elmorsy; Attalla El-kott; Kareem Morsy; Ali AlSheri; Sally Negm; Sameh Saber

doi:10.2147/ijn.s502833

journal article Open Access Jan 01, 2025

Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions

Alexandru Hasan Simona Cavalu

Ahmed Kira

Rabab Hamad Mustafa Abdel-Reheim Elsayed Elmorsy

Attalla El-kott Kareem Morsy

Ali AlSheri Sally Negm

Sameh Saber

International Journal of Nanomedicine Vol. Volume 20 pp. 741-770 · Informa UK Limited

View at Publisher Save 10.2147/ijn.s502833

Topics

No keywords indexed for this article. Browse by subject →

References

172

[1]

Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN

Shaoming Wang, Rongshou Zheng, Jiayue Li et al.

The Lancet Gastroenterology & Hepatology 2024 10.1016/s2468-1253(23)00366-7

[2]

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Mathieu Laversanne, Hyuna Sung et al.

CA: A Cancer Journal for Clinicians 2024 10.3322/caac.21834

[3]

Koziolek Adv Drug Delivery Rev (2016) 10.1016/j.addr.2016.03.009

[4]

Lopetuso Eur Rev Med Pharmacol Sci (2015)

[5]

Stuurman Clin Pharmacokinet (2013) 10.1007/s40262-013-0040-2

[6]

Xu J Control Release (2020) 10.1016/j.jconrel.2020.04.006

[7]

Aleksakhina Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer (2019) 10.1016/j.bbcan.2019.188310

[8]

Bazak J Cancer Res Clin Oncol (2015) 10.1007/s00432-014-1767-3

[9]

Bernkop-Schnürch Drug Discov Today (2005) 10.1016/j.ddtec.2005.05.001

[10]

Raj RSC Adv (2018) 10.1039/c8ra01898g

[11]

Zeeshan Int J Pharm (2019) 10.1016/j.ijpharm.2018.12.074

[12]

Shuja Dev Medico-Life-Sci (2024) 10.69750/dmls.01.01.015

[13]

Wilczyński Cell Commun Signaling (2024) 10.1186/s12964-024-01857-7

[14]

The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics

Jai Prakash, Yuval Shaked

Cancer Discovery 2024 10.1158/2159-8290.cd-24-0002

[15]

Eckford Chem Rev (2009) 10.1021/cr9000226

[16]

Tumor delivery of macromolecular drugs based on the EPR effect

Vladimir Torchilin

Advanced Drug Delivery Reviews 2011 10.1016/j.addr.2010.03.011

[17]

Lingen Oral Oncol (2008) 10.1016/j.oraloncology.2007.06.011

[18]

(2005)

[19]

Sciubba Ame J Clin Dermatol (2001) 10.2165/00128071-200102040-00005

[20]

Chaturvedi BMJ (2019) 10.1136/bmj.l2142

[21]

Candotto Oral Implantol (2017) 10.11138/orl/2017.10.3.209

[22]

Rubenstein Gastroenterology (2015) 10.1053/j.gastro.2015.04.053

[23]

Barrett Esophagus

Prateek Sharma

JAMA 2022 10.1001/jama.2022.13298

[24]

Lagergren Ca a Cancer J Clinicians (2013) 10.3322/caac.21185

[25]

Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis

Basile Njei, Thomas R McCarty, John W Birk

Journal of Gastroenterology and Hepatology 2016 10.1111/jgh.13289

[26]

Launoy Eur J Cancer Prev (2017) 10.1097/cej.0000000000000308

[27]

Teng Cancer Biol Med (2024)

[28]

Anaparthy Nat Rev Gastroenterol Hepatol (2014) 10.1038/nrgastro.2014.69

[29]

Turati Ann Oncol (2013) 10.1093/annonc/mds244

[30]

Olliver Cancer Epidemiol Biomarkers Prev (2005) 10.1158/1055-9965.epi-04-0509

[31]

Freedman Gut (2011) 10.1136/gut.2010.233866

[32]

Sardana Food Funct (2018) 10.1039/c7fo01908d

[33]

(2020)

[34]

Brenner Cancer Epidemiol (2009) 10.1007/978-1-60327-492-0_23

[35]

Noto PLoS Pathogens (2017) 10.1371/journal.ppat.1006573

[36]

Peleteiro Dig Dis Sci (2015) 10.1007/s10620-015-3624-x

[37]

Steele Dis Colon Rectum (2014) 10.1097/dcr.0b013e3182a586e7

[38]

Sawicki Cancers (2021) 10.3390/cancers13092025

[39]

Yashiro World J Gastroenterol (2014) 10.3748/wjg.v20.i44.16389

[40]

Fearon J British Surg (2013) 10.1002/bjs.8988

[41]

Matsuda Annals Gastroenterol Surg (2018) 10.1002/ags3.12061

[42]

Morino Anticancer Res. (2024) 10.21873/anticanres.16975

[43]

Oehler Cancer Treat Rev (2006) 10.1016/j.ctrv.2006.01.002

[44]

Hajj J Clin Oncol (2015) 10.1200/jco.2014.59.9787

[45]

Meyer British J Radiol (2000) 10.1259/bjr.73.872.11026861

[46]

Wisdom Proc Natl Acad Sci (2019) 10.1073/pnas.1901562116

[47]

Guo Cancer Invest (2016) 10.3109/07357907.2015.1104689

[48]

Cremolini Lancet Oncol (2015) 10.1016/s1470-2045(15)00122-9

[49]

Altun Iran J Public Health (2018)

[50]

Molecular aspects of cancer cell resistance to chemotherapy

Magali Rebucci, Carine Michiels

Biochemical Pharmacology 2013 10.1016/j.bcp.2013.02.017

Showing 50 of 172 references

Metrics

17

Citations

172

References

Details

Published: Jan 01, 2025
Vol/Issue: Volume 20
Pages: 741-770
License: View

Authors

Cite This Article

Alexandru Hasan, Simona Cavalu, Ahmed Kira, et al. (2025). Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions. International Journal of Nanomedicine, Volume 20, 741-770. https://doi.org/10.2147/ijn.s502833

Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions

You May Also Like